https://www.avient.com/sites/default/files/2020-08/colormatrix-aazure-brochure-1.pdf
It is designed for convertors
to add to preforms to allow for higher levels of
rPET, reducing risk from off-taste and improving
the sustainability of PET bottles.
Melt processing of ColorMatrix AAzure
products is carried out at typical PET
processing conditions at recommended
dose rates, which range from 0.01%
to 0.13%.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2022-07/Avient Announces Second Quarter 2022 Results_1.pdf
In
addition, we embarked on a formal process to explore the sale of our Distribution business and
are encouraged by the level of interest we have received from several potential buyers.”
Without giving effect to any impacts from the pending acquisition of Dyneema and potential sale
of Avient Distribution, the company provided third quarter adjusted EPS guidance of $0.80, a 14%
increase from the prior year quarter, and maintained its full year adjusted EPS guidance of $3.50.
We expect demand in Asia to improve from the prior quarter and growth to continue in the
Americas, offsetting softening conditions in Europe and weaker foreign exchange,” said Jamie A.
https://www.avient.com/sites/default/files/2025-05/Avient Announces First Quarter 2025 Results_0.pdf
Khandpur.
2
“From a regional perspective, Asia and Latin America delivered strong results, growing organic
sales 9% and 17%, respectively,” Dr.
For the most
part, we source raw materials and manufacture our products locally in the regions we serve, so
we expect minimal direct impact from tariffs announced to date.
Management excludes intangible asset amortization from adjusted EPS as it believes excluding acquired intangible asset
amortization is a useful measure of current period earnings per share.
https://www.avient.com/sites/default/files/resources/PolyOne%2520India%2520Terms%2520and%2520Conditions%2520of%2520Sale%2520of%2520Products.May%25202016.pdf
Buyer assumes all risk of patent infringement by
reason of any use Buyer makes of the Product in combination with other
substances or in the operation of any process, and all infringement arising out
of Seller’s compliance with Buyer’s designs, specifications or instructions,
and Buyer shall defend, indemnify and hold Seller harmless from and against
the same.
If a present or future law, governmental decree,
order, regulation, or ruling under any existing or future legislation prevents
Seller from increasing or revising the price as provided herein, or nullifies or
reduces any price or price increase hereunder, upon written notice from one to
the other Seller and Buyer will attempt to identify mutually agreeable
changes to conform this contract with such law, decree, order, regulation, or
ruling.
No statement of agreement, oral or
written, made before or at the signing of this contract shall vary or modify the
written terms hereof, and neither party shall claim any amendment,
modification or release from any provision hereof unless such change occurs
in a writing signed by the other party and specifically identifying it as an
amendment to this contract.
https://www.avient.com/sites/default/files/2020-08/specialty-dispersions-overview.pdf
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable
indication of performance or properties obtained or obtainable on larger-scale equipment.
Processing conditions can cause material properties to shift from the values stated in the information.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
The loading level of ZPT
ranged from 1000 ppm to 3000 ppm in the final formula-
tion.
Tensile bars were die-cut (type
IV) from plaques and tested at 20 in.
The agar was rinsed from the surface, and the samples
were reexamined for the presence of staining.
https://www.avient.com/sites/default/files/2023-01/Hydrocerol Chemical Foaming Agents for Injection Molding Technical Bulletin.pdf
To achieve a uniform foam distribution and a solid
skin, the gas should expand from the inside to the
outside of the polymer melt after injection.
The gas expansion pressure supports
the foam core structure formation while reducing the
appearance of sink marks, as it expands from within.
Processing conditions can cause material properties to shift from the values stated in the information.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520RW%2520Baird%2520Conference%2520w%2520non-GAAP.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which
could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated
savings and operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition
being accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability
and cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with
inadequate liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working
capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates
and changes in the rate of inflation
S&P 500
-150%
-50%
50%
150%
250%
350%
450%
550%
POL S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 YTD 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.9% 12 – 16%
Global Specialty Engineered
Materials
1.1% 12.1% 12 – 16%
Designed Structures & Solutions -- 7.6% 8 – 10%
Performance Products &
Solutions
5.5% 8.1% 9 – 12%
Distribution 2.6% 6.2% 6 – 7.5%
2) Specialty Platform % of
Operating Income
6.0% 65% 65 – 75%
3) ROIC* 5.0% 10.6% 15%
4) Adjusted EPS Growth N/A 37%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
32% Adjusted EPS CAGR from 2011
2015 EPS: $2.50
2011 EPS: $0.82
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement
Several Levers to
Drive Growth
Mid Single Digit Revenue Growth
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
31%
2006 2013
Specialty Platform
Gross Margin %
20%
43%
2006 2013
Specialty Vitality Index Target ≥ 35%
Vitality Products
+ 700 to 1000 bps
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions)
TBD TBD $800 $450 $450 $1,700
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of September 30, 2014
Debt Maturities & Pension Funding – 9/30/14
Net Debt / EBITDA* = 1.7x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of September 30, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 9/30/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.5 million shares in
Q3 2014
Repurchased 9.7 million
shares since early 2013
10.3 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
$0.16
$0.20
$0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2021-01/case-study-one-pager-surround-automotive-ev-connector-charger.pdf
MAJOR TIER 1
SUPPLIER
C O N N E C T O R C O V E R
• EMI-shielding performance at frequencies from 30 MHz up
to 2 GHz
• Excellent dimensional stability
• Must meet robust mechanical property targets including
tensile strength and elongation at break
• Worked in close collaboration with the OEM from
the start of the development process in order to
fully understand their key requirements
• Developed a customized material providing the
required EMI-shielding performance which,
removing the need for secondary metallization
manufacturing processes, reduced cycle time
Surround™ NN- 14 NICF SIP Black
Formulation
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-05/Avient Zertifikat englisch - 2024.pdf
SKZ Standart-Dokumentvorlage
This certificate is valid from: 23.05.2024 bis: 19.05.2027
Certificate No.: 000870.E/24.R
Würzburg, 23.05.2024
Benjamin Kirchgeßner
Certification Body
Certificate
The SKZ - Cert GmbH certifies to the company
Avient Th.
This certificate is valid from: 23.05.2024 bis: 19.05.2027
Certificate No.: 000870.E/24.R
Würzburg, 23.05.2024
Benjamin Kirchgeßner
Certification Body
Appendix to certification number: 000870.E/24.R
Avient Th.